MARKET

ICU

ICU

SeaStar Medical Holding Corp
NASDAQ
0.2944
+0.0014
+0.48%
After Hours: 0.2645 -0.0299 -10.16% 19:56 12/18 EST
OPEN
0.3120
PREV CLOSE
0.2930
HIGH
0.3146
LOW
0.2936
VOLUME
1.12M
TURNOVER
--
52 WEEK HIGH
3.070
52 WEEK LOW
0.2900
MARKET CAP
10.61M
P/E (TTM)
-0.1792
1D
5D
1M
3M
1Y
5Y
1D
SeaStar Medical Shareholders Approve 1-for-10 Reverse Split
TipRanks · 4h ago
SeaStar Medical Announces 1-For-10 Reverse Stock Split, Effective Jan. 2, 2026
Benzinga · 5h ago
SEASTAR MEDICAL HOLDING CORP - APPROVES 1-FOR-10 REVERSE STOCK SPLIT - SEC FILING
Reuters · 5h ago
Seastar Medical Holding Corporation Held Special Shareholder Meeting
Reuters · 5h ago
Weekly Report: what happened at ICU last week (1208-1212)?
Weekly Report · 3d ago
SeaStar Medical CFO Michael Messinger Acquires Common Shares
Reuters · 12/11 23:50
Seastar Medical Holding Corporation Files Initial Beneficial Ownership Statement for CFO Michael Messinger
Reuters · 12/08 21:51
Weekly Report: what happened at ICU last week (1201-1205)?
Weekly Report · 12/08 10:08
More
About ICU
SeaStar Medical Holding Corporation is a commercial-stage medical technology company, which is focused on transforming treatments for critically ill patients facing organ failure and potential loss of life. The Company’s Selective Cytopheretic Device (SCD) is designed as a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation and creates a cascade of events that wreak havoc in the patient’s body. It has broad potential applications for patients suffering from both acute and chronic kidney disease as well as cardiovascular and other serious inflammatory diseases. Its SCD therapy is an extracorporeal synthetic membrane device designed to bind activated leukocytes (neutrophils and monocytes) when integrated into an existing continuous renal replacement therapy (CRRT) circuit in conjunction with the use of regional citrate anticoagulation (RCA).

Webull offers SeaStar Medical Holding Corp stock information, including NASDAQ: ICU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICU stock methods without spending real money on the virtual paper trading platform.